Rob Dee

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden et al. · Leukemia · 2003 · 879 citations

Hematological Malignancy, Polymerase Chain Reaction, Prognostic Biomarkers +11

<i>PHOX2B</i> Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma

Janine Stutterheim, Annemieke Gerritsen, Lily Zappeij‐Kannegieter et al. · Journal of Clinical Oncology · 2008 · 97 citations

Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway

Micha Nethe, Eloise C. Anthony, Mar Fernandez‐Borja et al. · Journal of Cell Science · 2010 · 90 citations

Cell Adhesion, Molecular Biology, Cytoskeleton +18

Detecting Minimal Residual Disease in Neuroblastoma: The Superiority of a Panel of Real-Time Quantitative PCR Markers

Janine Stutterheim, Annemieke Gerritsen, Lily Zappeij‐Kannegieter et al. · Clinical Chemistry · 2009 · 76 citations · Full text

Rho GTPase Expression in Human Myeloid Cells

Suzanne F. G. van Helden, Eloise C. Anthony, Rob Dee et al. · PLoS ONE · 2012 · 32 citations · Full text